These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 5012543)

  • 21. [On the therapy of cerebral and peripheral circulatory disorders].
    Klein L
    Med Welt; 1969 Aug; 35():1913-6. PubMed ID: 4390197
    [No Abstract]   [Full Text] [Related]  

  • 22. [Diagnosis and therapy of peripheral disorders of the blood circulation with special consideration of the effect of beta pyridyl carbinol].
    Broghammer H
    Med Welt; 1967 Apr; 17():1091-100. PubMed ID: 5586962
    [No Abstract]   [Full Text] [Related]  

  • 23. Peripheral vasodilator drugs.
    Br Med J; 1969 Jul; 3(5661):38-40. PubMed ID: 5787285
    [No Abstract]   [Full Text] [Related]  

  • 24. Responsiveness of various symptoms of vascular disorders to calcium antagonist.
    Verhaegen H; Reyntjens A; Horig C; Pötsch W
    Angiology; 1979 Jul; 30(7):447-53. PubMed ID: 380409
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experience with the vasodilator agent spasmocyclone].
    Priessnitz O
    Med Welt; 1966 Jun; 26():1433-6. PubMed ID: 5962718
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of 1-(4-oxyphenyl)-1-oxy-2-n-butylaminoethane sulfate on peripheral vascular diseases].
    Giulini SM; Agus GB; De Cristoforo A
    Minerva Cardioangiol; 1973 Jun; 21(6):434-8. PubMed ID: 4146376
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of nicergoline in peripheral arteriopathies of the lower limbs. Double-blind study].
    Coscia M
    Minerva Cardioangiol; 1972 Sep; 20(9):497-504. PubMed ID: 4561065
    [No Abstract]   [Full Text] [Related]  

  • 28. [Report on experiences with the complex treatment of cerebral and peripheral circulatory disorders].
    Basarab A
    Med Welt; 1973 Apr; 24(16):650-2. PubMed ID: 4756330
    [No Abstract]   [Full Text] [Related]  

  • 29. [Vasodilation caused by inhibition of calcium ions as a factor of increasing oxygen transport in peripheral vascular diseases].
    Pola P; Savi L; Dal Lago A; Zucchiatti V
    Clin Ter; 1977 Jun; 81(5):417-31. PubMed ID: 884936
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of angiodystrophic skin diseases with ginkgo-biloba].
    Nazzaro P; Di Carlo A
    Minerva Med; 1973 Nov; 64(79 Suppl):4198-200. PubMed ID: 4592297
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experimental and clinical experiences with Encephabol therapy in gerontopsychiatry].
    Hádlík J; Sindelárová M; Svestka J
    Cesk Psychiatr; 1971 Jun; 67(3):129-33. PubMed ID: 5087313
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical study of the cerebrovascular action of pentoxifylline].
    Shtok VN; Fedorova NV; Gadanova IV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):60-6. PubMed ID: 7064607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trazodone in the treatment of organic brain syndromes, with special reference to psychogeriatrics.
    Nair NP; Ban TA; Hontela S; Clarke R
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):769-75. PubMed ID: 4201974
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical studies on the effect of hexobendine (Ustimon) on cerebral circulatory disorders].
    Prosenz P; Tschabitscher H
    Wien Klin Wochenschr; 1965 Dec; 77(48):953-5. PubMed ID: 5331101
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of peripheral and cerebral circulation disorders. Experiences with bencyclan-hydrogenfumarate (Fludilat)].
    Frercks J
    Munch Med Wochenschr; 1971 Oct; 113(40):1293-8. PubMed ID: 5171108
    [No Abstract]   [Full Text] [Related]  

  • 36. Experimental clinical studies on the effect of eburnamonine in cerebrovascular disorders.
    Jansen W; O'Connolly M; Lehmann E; Mayer M
    Pharmacopsychiatry; 1986 Sep; 19(5):389-94. PubMed ID: 3534902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Can psychiatric disorders on the aged be influenced by affecting the cerebral circulation?].
    Lambert PA; Bouchardy M
    Sem Ther; 1968 Dec; 44(10):654-5. PubMed ID: 5706292
    [No Abstract]   [Full Text] [Related]  

  • 38. [Electroencephalographic changes during pyrithioxine (Encephabol) therapy].
    Misurec J; Hádlík J
    Cesk Psychiatr; 1971 Jun; 67(3):134-42. PubMed ID: 5087314
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experiences with the new vasotherapeutic drug Trental in dermatology].
    Herger R
    Fortschr Med; 1972 Aug; 90(24):865-72. PubMed ID: 4639351
    [No Abstract]   [Full Text] [Related]  

  • 40. [Attempt at classification of various special indications for 1035 MD (sureptil) in neuropsychiatry].
    Bornstein S; Czermak M; Kannas S; Postel J
    Ann Med Psychol (Paris); 1969 Jan; 1(1):139-44. PubMed ID: 4388586
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.